News GB Sciences, Inc.

Equities

GBLX

US3615441090

Market Closed - OTC Markets Other stock markets 03:40:16 2024-05-07 pm EDT			5-day change	1st Jan Change
0.00785 ^USD	-4.27%		+21.54%	+23.44%

Feb. 12	GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	CI
2023	GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	CI

Summary

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 12	CI
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	Nov. 20	CI
GB Sciences, Inc. Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-14	CI
GB Sciences, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-07-14	CI
GB Sciences, Inc. Auditor Raises 'Going Concern' Doubt	23-07-13	CI
Gb Sciences' First-In-Class Parkinson's Disease Therapy Successfully Completes Dose Response Study At the University of Lethbridge	23-07-11	CI
GB Sciences, Inc. announced a financing transaction	23-06-29	CI
GB SCIENCES INC : Change in Directors or Principal Officers (form 8-K)	23-04-14	AQ
GB Sciences, Inc. Announces Executive Changes	23-04-14	CI
GB SCIENCES INC : Submission of Matters to a Vote of Security Holders (form 8-K)	23-03-10	AQ
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	23-02-03	AQ
GB Sciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-03	CI
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22	GL
Gb Sciences Identifies Novel Cannabis-Inspired Mixtures as Anti-Inflammatory Therapies Based on Proprietary AI-Enabled Drug Discovery Platform	22-12-22	GL
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	22-12-12	GL
Gb Sciences Addresses Growing Need for Anxiety and Depression Medications With Non-Psychedelic, Kava-Based Formulations	22-12-12	AQ
GB SCIENCES INC Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)	22-11-09	AQ
GB Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-09	CI
Gb Sciences Co-Publishes Study Demonstrating Anti-Inflammatory Properties of Cannabis Ingredients	22-11-01	AQ
TODAY: Gb Sciences' President Demonstrates Benefits of AI-Enabled Drug Discovery Engine for Novel Plant-Inspired Pharmaceuticals at 10th Annual Drug Discovery Strategic Summit	22-10-27	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News GB Sciences, Inc.

Equities

GBLX

US3615441090

Summary

Filters